Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001589795 | SCV001815257 | likely pathogenic | not provided | 2019-10-15 | criteria provided, single submitter | clinical testing | Intronic +5 splice site variant in a gene for which loss-of-function is a known mechanism of disease, and both in silico predictors and evolutionary conservation support a deleterious effect; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 7668256, 27350676) |
3billion, |
RCV001810102 | SCV002058404 | likely pathogenic | Duchenne muscular dystrophy | 2024-07-30 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v4.0.0 dataset. In silico tools predict the variant to alter splicing and produce an abnormal transcript [SpliceAI: 0.91 (>=0.2)]. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV001213207). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |
Revvity Omics, |
RCV001589795 | SCV003829333 | likely pathogenic | not provided | 2022-11-29 | criteria provided, single submitter | clinical testing |